CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1972; 22:357-359
doi: 10.3322/canjclin.22.6.357
© 1972 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, H. R. K.
Right arrow Articles by Graber, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barber, H. R. K.
Right arrow Articles by Graber, E. A.

CA: A Cancer Journal for Clinicians, Vol 22, 357-359, Copyright © 1972 by American Cancer Society


The PMPO Syndrome (Postmenopausal Palpable Ovary Syndrome)

Hugh R. K. Barber M.D.1 and Edward A. Graber M.D.2

1 Director of Obstetrics and Gynecology, Lenox Hill Hospital, New York, New York; Attending Surgeon, Memorial Hospital for Cancer and Allied Diseases; Associate Attending Obstetrician Gynecologist, New York Hospital; and Clinical Associate Professor of Obstetrics and Gynecology, Cornell Medical School, New York.
2 Attending Obstetrician-Gynecologist and Associate Director of Obstetrics and Gynecology, Lenox Hill Hospital, New York, New York.

If we are to save more women and diminish the mortality rate from ovarian cancer, we must become more liberal in our indications for operation. We suggest that the palpation of what appears to be a normal-sized ovary for a patient three to five years postmenopausal is indicative of an ovarian tumor and should be investigated promptly. These patients should not be followed and re-evaluated but rather subjected to proof as to the presence or absence of an ovarian tumor. To wait until one feels a solid tumor mass of up to 5 cm. and expect a cure is an exercise in fancy and futility.

John Gardner said, "We are all faced with wonderful opportunities brilliantly disguised as insoluble problems." Ovarian cancer is not insoluble. Perhaps, by adding a small segment at a time, the total picture will emerge to the benefit of our patients. Remember the PMPO Syndrome!







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by American Cancer Society.